Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is launching the new VisioNize® box 2,
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
Alembic Pharmaceutica
Since it’s an ingredient in so many foods, you h
In a world constantly in motion, Microbioz India r
India will produce about 300 million doses of Russia’s Sputnik V coronavirus vaccines next year, a Russian official was quoted as saying, almost three times the previously known number as deals are signed with more manufacturers.
Russia is already testing the first samples of Sputnik V that were created in India, its embassy in New Delhi said on Twitter on Friday, sharing a news story in which their vaccine czar Kirill Dmitriev has been quoted.
“In India, we’ve got agreements with four large manufacturers,” Dmitriev, the head of the Russian Direct Investment Fund (RDIF) told Rossiya 24 TV, according to news agency TASS.
“India will create about 300 million doses or more of the vaccine for all of us next year.”
India is the world’s biggest vaccine manufacturer and its pharmaceutical industry is freeing up capacity and accelerating investments before the global rush for COVID-19 shots.
India’s Hetero Biopharma has already announced a deal with the RDIF to create more than 100 million doses of Sputnik V, whose effectiveness has been found to be more than 91 percent in trials done outside India.
It wasn’t immediately clear which other Indian companies would produce the vaccine, though Dr. Reddy’s Laboratories Ltd is conducting clinical trials of it in India and will also distribute the final vaccine.
Indian officials have said they may approve some vaccines for emergency use authorization in the coming weeks. Up to now only three vaccines from Oxford-AstraZeneca, Pfizer/BioNTech and Indian firm Bharat Biotech have applied for urgent approval.
It is the world’s second-worst affected country after the United States, which has recorded 16.9 million cases.
